HIV-1 RNase H: recent progress in an exciting, yet little explored, drug target.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2006-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138955706777435733PMID 16787384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrase inhibitors to treat HIV/Aids

  2005cited by this paper
• Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones

  2005cited by this paper
• Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.

  2005cited by this paper
• Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision.

  2005cited by this paper
• New approaches toward anti-HIV chemotherapy.

  2005cited by this paper
• 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.

  2005cited by this paper
• Selective Inhibition of HIV‐1 Reverse Transcriptase (HIV‐1 RT) RNase H by Small RNA Hairpins and Dumbbells

  2004cited by this paper
• Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides.

  2004cited by this paper
• Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors.

  2003cited by this paper
• Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors.

  2003cited by this paper
• Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid*

  2003cited by this paper
• Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice.

  2003cited by this paper
• Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase

  2002cited by this paper
• Inhibitory effects of quinones on RNase H activity associated with HIV‐1 reverse transcriptase

  2002cited by this paper
• Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity.

  2002cited by this paper
• Inhibitor binding alters the directions of domain motions in HIV‐1 reverse transcriptase

  2002cited by this paper
• DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.

  2002cited by this paper
• Destabilization of the HIV-1 reverse transcriptase dimer upon interaction with N-acyl hydrazone inhibitors.

  2002cited by this paper
• A novel mechanism for inhibition of HIV-1 reverse transcriptase.

  2002cited by this paper
• Inhibitory effects of Korean plants on HIV‐1 activities

  2001cited by this paper
• The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages.

  2001cited by this paper
• Crystal structure of HIV‐1 reverse transcriptase in complex with a polypurine tract RNA:DNA

  2001cited by this paper
• Kaempferol acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency virus-1 reverse transcriptase.

  2001cited by this paper
• DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.

  2001cited by this paper
• Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection

  2000cited by this paper
• Inhibition of human immunodeficiency virus type 1 reverse transcriptase and ribonuclease H activities by constituents of Juglans mandshurica.

  2000cited by this paper
• Mutants of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Resistant to Nonnucleoside Reverse Transcriptase Inhibitors Demonstrate Altered Rates of RNase H Cleavage That Correlate with HIV-1 Replication Fitness in Cell Culture

  2000cited by this paper
• Inhibition of HIV-1 reverse transcriptase-catalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid.

  2000cited by this paper
• The Sequential Mechanism of HIV Reverse Transcriptase RNase H*

  2000cited by this paper
• Argentine plant extracts active against polymerase and ribonuclease H activities of HIV‐1 reverse transcriptase

  1999cited by this paper
• The P236L Delavirdine-Resistant Human Immunodeficiency Virus Type 1 Mutant Is Replication Defective and Demonstrates Alterations in both RNA 5′-End- and DNA 3′-End-Directed RNase H Activities

  1999cited by this paper
• Residues in the αH and αI Helices of the HIV-1 Reverse Transcriptase Thumb Subdomain Required for the Specificity of RNase H-catalyzed Removal of the Polypurine Tract Primer*

  1999cited by this paper
• Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function.

  1999cited by this paper
• Inhibitors of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase.

  1999cited by this paper
• Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

  1998cited by this paper
• Activation/Attenuation Model for RNase H

  1998cited by this paper
• Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.

  1998cited by this paper
• Mutations within the Primer Grip Region of HIV-1 Reverse Transcriptase Result in Loss of RNase H Function*

  1997cited by this paper
• Alanine-scanning Mutations in the “Primer Grip” of p66 HIV-1 Reverse Transcriptase Result in Selective Loss of RNA Priming Activity*

  1997cited by this paper
• Mutating a conserved motif of the HIV-1 reverse transcriptase palm subdomain alters primer utilization.

  1997cited by this paper
• Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.

  1997cited by this paper
• Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization.

  1996cited by this paper
• Nevirapine Alters the Cleavage Specificity of Ribonuclease H of Human Immunodeficiency Virus 1 Reverse Transcriptase (*)

  1995cited by this paper
• The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.

  1995cited by this paper
• Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide.

  1994cited by this paper
• Effect of a thiobenzimidazolone derivative on DNA strand transfer catalyzed by HIV-1 reverse transcriptase.

  1994cited by this paper
• Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.

  1994cited by this paper
• Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagine 494, and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type I reverse transcriptase. Expression and biochemical analysis.

  1994cited by this paper
• 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.

  1994cited by this paper
• Synthesis of naphthalenesulfonic acid small molecules as selective inhibitors of the DNA polymerase and ribonuclease H activities of HIV-1 reverse transcriptase.

  1994cited by this paper
• The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.

  1993cited by this paper
• Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.

  1993cited by this paper
• Two defective forms of reverse transcriptase can complement to restore retroviral infectivity.

  1993cited by this paper
• Crystal structure of Escherichia coli RNase HI in complex with Mg2+ at 2.8 Å resolution: Proof for a single Mg2+‐binding site

  1993cited by this paper
• Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.

  1992cited by this paper
• Mechanism and fidelity of HIV reverse transcriptase.

  1992cited by this paper
• Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase.

  1992cited by this paper
• Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase.

  1991cited by this paper
• Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate.

  1991cited by this paper
• Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function

  1991cited by this paper
• Human immunodeficiency virus reverse transcriptase displays a partially processive 3' to 5' endonuclease activity.

  1991cited by this paper
• Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled.

  1991cited by this paper
• Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities.

  1991cited by this paper
• Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase.

  1990cited by this paper
• Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase

  1990cited by this paper
• The inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivatives

  1990cited by this paper
• Inhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanions

  1989cited by this paper
• Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

  1986cited by this paper

• Ultrasensitive RNase H activity detection using the transcription-based hybrid probe and CRISPR/cas12a signal amplifier

  2025cites this paper
• DNA/RNA chimera-templated copper nanoclusters for label-free detection of reverse transcription-associated ribonuclease H

  2020cites this paper
• Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H

  2020cites this paper
• Targeting HIV-1 RNase H: N’-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants

  2020cites this paper
• Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.

  2019cites this paper
• Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds

  2018cites this paper
• Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication

  2018cites this paper
• Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors

  2016cites this paper
• (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.

  2015cites this paper
• Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.

  2015cites this paper
• Past and Future. Current Drugs Targeting HIV-1 Integrase and Reverse Transcriptase-Associated Ribonuclease H Activity: Single and Dual Active Site Inhibitors

  2014cites this paper
• Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives

  2014cites this paper
• Design, Synthesis, and Biological Evaluation of 1,3‐Diarylpropenones as Dual Inhibitors of HIV‐1 Reverse Transcriptase

  2014cites this paper
• Characterization of the mechanism of action of new HIV-1 reverse transcriptase-associated ribonuclease H inhibitors

  2014cites this paper
• Recent progress in the research of small molecule HIV-1 RNase H inhibitors.

  2014cites this paper
• Inhibition of Foamy Virus Reverse Transcriptase by Human Immunodeficiency Virus Type 1 RNase H Inhibitors

  2014cites this paper
• 6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach.

  2013cites this paper
• ZnO-mediated regioselective C-arylsulfonylation of indoles: a facile solvent-free synthesis of 2- and 3-sulfonylindoles and preliminary evaluation of their activity against drug-resistant mutant HIV-1 reverse transcriptases (RTs)

  2013cites this paper
• Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities.

  2013cites this paper
• Molecular aspects of the RT/drug interactions. Perspective of dual inhibitors.

  2013cites this paper
• Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.

  2012cites this paper
• Structural modulation study of inhibitory compounds for ribonuclease H activity of human immunodeficiency virus type 1 reverse transcriptase.

  2012cites this paper
• HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions

  2012cites this paper
• New Anthraquinone Derivatives as Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Function

  2012cites this paper
• Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach.

  2012cites this paper
• Targeting Divalent Metal Ions at the Active Site of the HIV-1 RNase H Domain: NMR Studies on the Interactions of Divalent Metal Ions with RNase H and Its Inhibitors

  2011cites this paper
• Structural and Binding Analysis of Pyrimidinol Carboxylic Acid and N-Hydroxy Quinazolinedione HIV-1 RNase H Inhibitors

  2011cites this paper
• Diketo Acids Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

  2011cites this paper
• Alizarine derivatives as new dual inhibitors of the HIV‐1 reverse transcriptase‐associated DNA polymerase and RNase H activities effective also on the RNase H activity of non‐nucleoside resistant reverse transcriptases

  2011cites this paper
• Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.

  2011cites this paper
• Inhibition of HIV-1 reverse transcriptase associated activities by the hydroalcoholic extract of Casimiroa edulis seeds

  2011influential citation
• HIV-1 RT-associated RNase H function inhibitors: Recent advances in drug development.

  2010cites this paper
• Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition.

  2009cites this paper
• HIV-1-Inhibiting Activity of the Essential Oil of Ridolfia segetum and Oenanthe crocata

  2009cites this paper
• Validation of a computed radiography device to monitor the HIV-1 RNase H activity

  2009cites this paper
• Inhibition of HIV-1 ribonuclease H activity by novel frangula-emodine derivatives.

  2009cites this paper
• Preferred Sequences within a Defined Cleavage Window Specify DNA 3′ End-directed Cleavages by Retroviral RNases H*

  2009cites this paper
• Synthesis of the Naturally Occurring (-)-1,3,5-Tri-O-Caffeoylquinic Acid.

  2009cites this paper
• Recent advances in the research of HIV-1 RNase H inhibitors.

  2008cites this paper
• The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds.

  2008cites this paper